- Home
- NKTR vs CHN Comparison
NKTR vs CHN Comparison
Compare NKTR & CHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- CHN
- Stock Information
- Founded
- NKTR 1990
- CHN 1992
- Country
- NKTR United States
- CHN United States
- Employees
- NKTR N/A
- CHN N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- CHN Investment Managers
- Sector
- NKTR Health Care
- CHN Finance
- Exchange
- NKTR Nasdaq
- CHN Nasdaq
- Market Cap
- NKTR 108.3M
- CHN 125.8M
- IPO Year
- NKTR 1994
- CHN N/A
- Fundamental
- Price
- NKTR $23.47
- CHN $14.70
- Analyst Decision
- NKTR Strong Buy
- CHN
- Analyst Count
- NKTR 6
- CHN 0
- Target Price
- NKTR $77.50
- CHN N/A
- AVG Volume (30 Days)
- NKTR 4.6M
- CHN 31.8K
- Earning Date
- NKTR 08-07-2025
- CHN 01-01-0001
- Dividend Yield
- NKTR N/A
- CHN 0.19%
- EPS Growth
- NKTR N/A
- CHN N/A
- EPS
- NKTR N/A
- CHN N/A
- Revenue
- NKTR $87,248,000.00
- CHN N/A
- Revenue This Year
- NKTR N/A
- CHN N/A
- Revenue Next Year
- NKTR N/A
- CHN N/A
- P/E Ratio
- NKTR N/A
- CHN N/A
- Revenue Growth
- NKTR N/A
- CHN N/A
- 52 Week Low
- NKTR $6.48
- CHN $9.00
- 52 Week High
- NKTR $37.38
- CHN $12.98
- Technical
- Relative Strength Index (RSI)
- NKTR 64.13
- CHN 72.47
- Support Level
- NKTR $8.27
- CHN $14.71
- Resistance Level
- NKTR $26.59
- CHN $14.99
- Average True Range (ATR)
- NKTR 3.81
- CHN 0.21
- MACD
- NKTR 0.81
- CHN 0.05
- Stochastic Oscillator
- NKTR 52.67
- CHN 86.57
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About CHN China Fund Inc. (The)
CHINA FUND INC is a non-diversified, closed-end management investment company. Its investment objective is a long-term capital appreciation which it seeks to achieve by investing in equity securities with trading in China and outside China. It invests in various industries such as Insurance, Entertainment, Machinery, Electrical Equipment, Beverages, Hotels, Restaurants, and Leisure among others.